SIGYN THERAPEUTICS, INC. Fair Value Adjustment of Warrants
SIGYN THERAPEUTICS, INC. (SIGY) reported Fair Value Adjustment of Warrants of $17.50 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-11-14
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2025-06-30 was $17.50K.
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2024-12-31 was -$63.72K.
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2024-09-30 was $24.77K.
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2024 was -$38.95K.
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2023 was -$352.96K.
- SIGYN THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2017 was $181.90K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $17.50K derived: sum of 2 quarters · filed 2025-11-14 | $17.50K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $17.50K 10-Q · filed 2025-09-05 | $17.50K 10-Q · filed 2025-09-05 | ||
| 2024-12-31 | -$63.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$38.95K derived: sum of 2 quarters · filed 2025-11-14 | -$38.95K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $24.77K 10-Q · filed 2025-11-14 | $24.77K 10-Q · filed 2025-11-14 | ||
| 2023-12-31 | -$126.04K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$128.60K derived: sum of 2 quarters · filed 2025-04-15 | -$337.16K derived: sum of 3 quarters · filed 2025-04-15 | -$352.96K 10-K · filed 2025-04-15 |
| 2023-09-30 | -$2.57K 10-Q · filed 2024-11-19 | -$211.12K derived: sum of 2 quarters · filed 2024-11-19 | -$226.93K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | -$208.56K 10-Q · filed 2024-08-19 | -$224.36K 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | -$15.81K 10-Q · filed 2024-05-14 | |||
| 2017-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $321.51K derived: sum of 2 quarters · filed 2018-04-02 | $181.90K 10-K · filed 2018-04-02 | |
| 2017-09-30 | $366.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $226.89K 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | -$139.61K 10-Q · filed 2017-08-14 | |||
| 2016-09-30 | -$45.24K 10-Q · filed 2016-11-14 | -$31.90K derived: sum of 2 quarters · filed 2016-11-14 | -$66.31K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $13.34K 10-Q · filed 2016-08-04 | $21.07K 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | $7.72K 10-Q · filed 2016-05-09 |